Paris: French drugmaker Sanofi said on Thursday it would collaborate with the Michael J. Fox Foundation to test an early- stage experimental treatment for Parkinson`s disease.Under the terms of the collaboration, MJFF will sponsor a phase I clinical trial to study the safety and tolerability of Sanofi`s AVE8112, a drug that has shown promise in preclinical tests as a therapy for some of the psychiatric symptoms of the disease. Parkinson`s disease is a brain disorder that leads to shaking and difficulty with walking as well as mood changes and impaired memory.
Ruckus in Rajya Sabha over UPSC row
China finally admits to Ladakh incursion
CWG: Wrestlers Yogeshwar, Babita win gold
Trilokpuri mishap: E-rickshaw driver arrested